upper limit of vulnerability
Recently Published Documents


TOTAL DOCUMENTS

64
(FIVE YEARS 2)

H-INDEX

17
(FIVE YEARS 0)

2016 ◽  
Vol 39 (7) ◽  
pp. 652-657 ◽  
Author(s):  
MICHAEL PITTARO ◽  
WILLIAM DEFORGE ◽  
MARK W. KROLL

2014 ◽  
Vol 78 (7) ◽  
pp. 1606-1611 ◽  
Author(s):  
Soichiro Yamashita ◽  
Akihiro Yoshida ◽  
Koji Fukuzawa ◽  
Ryudo Fujiwara ◽  
Atsushi Suzuki ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
Nicholas P. Charteris ◽  
Bradley J. Roth

Researchers have suggested that the fate of a shock-induced wave front at the edge of a “virtual anode” (a region hyperpolarized by the shock) is a key factor determining success or failure during defibrillation of the heart. In this paper, we use a simple one-dimensional computer model to examine propagation speed through a hyperpolarized region. Our goal is to test the hypothesis that rapid propagation through a virtual anode can cause failure of propagation at the edge of the virtual anode. The calculations support this hypothesis and suggest that the time constant of the sodium inactivation gate is an important parameter. These results may be significant in understanding the mechanism of the upper limit of vulnerability.


2011 ◽  
Vol 27 (Supplement) ◽  
pp. OP48_1
Author(s):  
Soichiro Yamashita ◽  
Akihiro Yoshida ◽  
Asumi Takei ◽  
Kaoru Takami ◽  
Mitsuaki Ito ◽  
...  

2010 ◽  
Vol 88 (4) ◽  
pp. 422-428 ◽  
Author(s):  
Natnicha Kanlop ◽  
Krekwit Shinlapawittayatorn ◽  
Rattapong Sungnoon ◽  
Punate Weerateerangkul ◽  
Siriporn Chattipakorn ◽  
...  

Previous reports demonstrated that cilostazol, a phosphodiesterase 3 inhibitor, affected cellular electrophysiology and reduced episodes of ventricular fibrillation (VF) in patients with Brugada syndrome. However, its effects on VF induction and defibrillation efficacy have never been investigated. We tested the hypothesis that cilostazol increases the VF threshold (VFT) and decreases the upper limit of vulnerability (ULV) and the defibrillation threshold (DFT). A total of 48 pigs were randomly assigned to defibrillation and VF induction studies. The diastolic pacing threshold (DPT), VFT, ULV, DFT, and effective refractory period were determined before and after the infusion of cilostazol at 6 mg/kg, 3 mg/kg, or vehicle. The DPT was significantly increased after administration of 3 and 6 mg/kg cilostazol. The ULV and DFT were significantly decreased after administration of 6 mg/kg cilostazol only. The ULV in the 6 mg/kg group had 12% lower peak voltage and 25% lower total energy, and the DFT had 13% lower peak voltage and 25% lower total energy. The VFT was not altered in any experimental group. This study shows that cilostazol administration significantly increased the DPT, which was associated with significantly reduced DFT and ULV.


Sign in / Sign up

Export Citation Format

Share Document